Business
Manhattan Associates Set to Release Q3 Earnings on October 21

Manhattan Associates, Inc. (NASDAQ: MANH) is scheduled to announce its third-quarter earnings for the fiscal year 2025 on Tuesday, October 21, 2025, after market hours. Analysts anticipate that the company will report earnings of $1.18 per share and revenue of approximately $271.656 million for the quarter. This announcement will be followed by a conference call at 4:30 PM ET, where further insights into the company’s performance are expected.
This upcoming earnings report follows Manhattan Associates’ previous announcement on July 22, 2025, where the software solutions provider reported earnings of $1.31 per share, surpassing analyst expectations of $1.12 by $0.19. The company achieved a return on equity of 82.91% and a net profit margin of 20.91%. Revenue for that quarter reached $272.42 million, exceeding the anticipated $263.62 million.
Analysts project that Manhattan Associates will achieve earnings of $3 per share for the current fiscal year and approximately $4 per share for the next fiscal year. The company’s earnings guidance for fiscal year 2025 is set between $4.760 and $4.840 per share.
Stock Performance and Market Activity
Shares of Manhattan Associates opened at $196.83 on Monday, reflecting a 2.0% increase. Over the past twelve months, the stock has fluctuated between a low of $140.81 and a high of $312.60. Currently, the stock’s 50-day moving average stands at $210.37, while the 200-day moving average is at $196.77. The company boasts a market capitalization of $11.90 billion, with a price-to-earnings ratio of 54.98 and a beta of 1.12.
Recent trading activity has seen a notable interest from institutional investors. For instance, NewEdge Advisors LLC increased its holdings in Manhattan Associates by 3.3% during the second quarter, now owning 1,852 shares valued at $366,000. Other firms, including Smartleaf Asset Management LLC and Evergreen Capital Management LLC, have also raised their positions, indicating a robust interest in the stock’s potential.
Analyst Ratings and Recommendations
The stock has received varied ratings from analysts. Loop Capital recently adjusted its price target for Manhattan Associates from $170.00 to $200.00, maintaining a “hold” rating. In contrast, Raymond James Financial increased their target from $195.00 to $250.00 and assigned an “outperform” rating. Meanwhile, Morgan Stanley lowered its price objective from $205.00 to $195.00 with an “underweight” rating.
Overall, analysts maintain an average rating of “Moderate Buy” for Manhattan Associates, with a price target of approximately $222.91. As the company prepares for its earnings release, stakeholders will closely monitor both the results and the conference call for insights into future performance and strategy.
Manhattan Associates develops and maintains software solutions that streamline supply chains, inventory management, and omni-channel operations. Its offerings include the Warehouse Management Solution, Transportation Management Solution, and Manhattan Active Omni, among others. As the company continues to grow, its upcoming earnings report is set to provide significant insights into its operational successes and challenges.
-
Business5 days ago
UK to Finalize Stablecoin Regulations by 2026, Boosting Crypto Sector
-
Business6 days ago
U.S. and U.K. Target Cybercriminal Networks, Seize $15 Billion
-
Lifestyle5 days ago
KISS OF LIFE’s Natty Dazzles in Micro-Shorts at Seoul Event
-
World5 days ago
Military Artillery Plan Sparks Safety Concerns Along California Highway
-
Sports5 days ago
Domenico Doran’s Stellar Performance Leads Bishop Amat to Victory
-
World6 days ago
Trump Signals Reluctance to Sell Tomahawk Missiles to Ukraine
-
Business5 days ago
California to Eliminate All Plastic Bags from Stores by 2026
-
Entertainment5 days ago
Louisiana Senate Raises Concerns Over Medicaid Cuts Amid New Bill
-
Entertainment5 days ago
Utah Communities Rally as Government Shutdown Strains Resources
-
Science2 days ago
Ancient Dinosaur Discovery in Argentina Reveals Evolutionary Insights
-
Sports6 days ago
Trade Low, Trade High: Key NHL Players to Consider Now
-
Health2 days ago
Uncovering the Hidden Link Between Knee Pain and Hip Issues